Although data from IDI indicate that short-term outcomes--CD4 cell count, incidence of opportunistic infections and self-reported adherence--do not differ between patients attending regular care and those attending the pharmacy refill program,[22] outcomes may have been different for PF, NF and PWF. Here, CD4 is linked to Opportunistic infection.